跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
BIVALIRUDIN FOR INJECTION
Authorized
STANDARD
BIVALIRUDIN FOR INJECTION
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fb0a3eafee6f8365
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
fb0a3eafee6f8365
Drug Approval Canada Name
BIVALIRUDIN FOR INJECTION
Product Name
BIVALIRUDIN FOR INJECTION
Status
Marketed
Status Date
2023-05-01
Original Market Date
2023-05-01
Din
02511452
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
20:12.04.12
Atc Original
B01AE06 BIVALIRUDIN
Atc Name
b 01 ae 06
Aig Number
0148342001
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
BIVALIRUDIN
250 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fb0a3eafee6f8365
Type
Standard
Back to Health Canada Approvals
BIVALIRUDIN FOR INJECTION - Health Canada Drug Approval Details